Welcome

This website serves as a source of news and information for the residents of Bridgewater, Bound Brook, and surrounding communities regarding the remedy and restoration of the American Cyanamid Superfund Site now owned by Wyeth Holdings Corporation. Pfizer Inc assumed responsibility for the Site on October 15, 2009, through its larger acquisition of Wyeth. Although Pfizer never operated at the site, Pfizer takes its responsibility seriously and is aggressively working to improve site conditions.

Objectives

Under the oversight of the U.S. Environmental Protection Agency (USEPA) and the New Jersey Department of Environmental Protection (NJDEP), Pfizer is working to accomplish four key objectives:

1. To implement a remediation program that is protective of human health and the environment;
2. To ensure that site remediation activities facilitate reuse and redevelopment of portions of the property;
3. To preserve and enhance the ecological assets of the property in a manner that creates value in the Raritan River regional ecosystem; and
4. To position the property as an asset to the local community and the region.

March 2012

The USEPA released the Proposed Plan for the American Cyanamid Superfund Site on February 16, 2012.  This plan identifies the preferred alternative for addressing the site-wide soils, groundwater, and the impoundment contents that have not yet been remediated with the exception of Impoundment 1 and 2 and provides the rationale for those preferences.

USEPA held a public meeting on March 8, 2012 to explain the Proposed Plan and all of the alternatives presented in the Feasibility Study.  USEPA will accept written comments on the Proposed Plan during the public comment period which runs through May 15, 2012.

The Proposed Plan and Site-Wide Feasibility Study, and other supporting documents, are available to the public at the Bridgewater Township Branch of the Somerset County Library, the USEPA Region 2 Records Center, and the New Jersey Department of Environmental Protection.